Updated Jul 16, 2026
Hunt Jonathan Robert is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $71K. Historical track record: 1/5 stars across 5 tracked purchases.
Jonathan Robert Hunt is the Chief Accounting Officer and Chief Financial Officer at Perspective Therapeutics, Inc., a company focused on developing radiopharmaceuticals for cancer treatment. He has been involved in the company's financial operations and regulatory filings.
| Role | Insider |
|---|---|
| Notability | 20/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★☆☆☆☆ (1/5) |
|---|---|
| Total purchases tracked | 5 |
| Purchases with forward-return data | 5 |
| 30-day win rate | 2000% |
| 90-day win rate | 2000% |
| Avg 5-day return | +1200.19% |
| Avg 30-day return | -413.10% |
| Avg 90-day return | +633.68% |
| Best 30-day return | +2270.53% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-11-17 | CATX | Perspective Therapeutics, Inc. | P — Open-market purchase | 11.0K | $2.03 | $22K |
| 2024-11-27 | CATX | Perspective Therapeutics, Inc. | P — Open-market purchase | 10.0K | $3.88 | $39K |
| 2024-11-27 | CATX | Perspective Therapeutics, Inc. | P — Open-market purchase | 2.4K | $3.60 | $9K |
| 2024-11-27 | CATX | Perspective Therapeutics, Inc. | P — Open-market purchase | 29 | $3.94 | $114 |
| 2024-11-27 | CATX | Perspective Therapeutics, Inc. | P — Open-market purchase | 400 | $3.55 | $1K |
Jonathan Robert Hunt is the Chief Accounting Officer and Chief Financial Officer at Perspective Therapeutics, Inc., a company focused on developing radiopharmaceuticals for cancer treatment. He has been involved in the company's financial operations and regulatory filings.…
Recorded transactions: 5 open-market purchases ($71K) and 0 open-market sales () across all tracked filings.
Across 5 tracked purchases, Hunt Jonathan Robert averaged -413.1% avg 30-day return with a 2000% 30-day win rate. InsiderAlpha rates the track record at 1/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hunt Jonathan Robert profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.